Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “asthma”

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency DepartmentRecruiting
NCT05691218NAUpdated Aug 20, 2026
Sponsor: Poitiers University Hospital
Moderate Asthma Exacerbation · Severe Asthma Exacerbation
France
Tezspire Cardiac Events PASSRecruiting
NCT06951867N/AUpdated Aug 20, 2026
Sponsor: AstraZeneca
Cardiovascular Events · MACE
United States, Denmark, France, Germany
To Identify Persons Who Are Susceptible to WSP-induced Inflammation and Examine the Role of GSTM1 and Other Factors in This SusceptibilitySuspended
NCT02767973NAUpdated Aug 20, 2026
Sponsor: University of North Carolina, Chapel Hill
Airway Inflammation · Allergic Asthma
United States
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaRecruiting
NCT05562466Phase 3Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Asthma
Argentina, Austria, Brazil, Bulgaria, Colombia +12 more
Efficacy of L-menthol on Breathlessness in AsthmaRecruiting
NCT07500974Phase 2Updated Aug 19, 2026
Sponsor: Region Skane
Asthma
Sweden
Respiratory Admittance by Oscillometry in ChildrenNot Yet Recruiting
NCT07771608N/AUpdated Aug 19, 2026
Sponsor: Central Hospital, Nancy, France
Asthma (Diagnosis)
Washington University Severe Asthma Research Program IIICompleted
NCT01716494N/AUpdated Aug 19, 2026
Sponsor: Washington University School of Medicine
Asthma
United States
Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance InhalersCompleted
NCT05689983Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: Washington University School of Medicine
Asthma in Children · Nonadherence, Medication
United States
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe AsthmaNot Yet Recruiting
NCT07772921Phase 3Updated Aug 19, 2026
Sponsor: Pfizer
Asthma
United States
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionRecruiting
NCT06829784Phase 3Updated Aug 19, 2026
Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Asthma
China
Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance InhalersActive Not Recruiting
NCT05111262Phase 1, Phase 2Updated Aug 19, 2026
Sponsor: Washington University School of Medicine
Asthma · Nonadherence, Medication
United States
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With AsthmaRecruiting
NCT05222529Phase 2Updated Aug 19, 2026
Sponsor: Novartis Pharmaceuticals
Asthma
Bulgaria, Colombia, Guatemala, Hungary, Poland +3 more
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentRecruiting
NCT07444567Phase 3Updated Aug 19, 2026
Sponsor: AstraZeneca
Asthma · Eosinophilic Granulomatosis With Polyangiitis (EGPA) · Hypereosinophilic Syndrome (HES)
United States, Argentina, Austria, Belgium, Canada +9 more
Bilevel Positive Airway Pressure (BPAP) for Severe AsthmaRecruiting
NCT07582211NAUpdated Aug 18, 2026
Sponsor: Columbia University
Pediatric Asthma · Acute Asthma · BiPAP · Non-invasive Positive Pressure Ventilation
United States
Changes in Eosinophil Cationic Protein and Sputum Eosinophils Following Allergen ImmunotherapyCompleted
NCT07694947NAUpdated Aug 18, 2026
Sponsor: Mansoura University Hospital
Allergic Asthma
Egypt
Real World and Genomic Data Based Asthma Insight Through Network AnalysisCompleted
NCT06623435N/AUpdated Aug 18, 2026
Sponsor: Icahn School of Medicine at Mount Sinai
Asthma
United States
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese PopulationRecruiting
NCT06419413N/AUpdated Aug 18, 2026
Sponsor: AstraZeneca
Asthma
China
Physical Activity Promotion and Clinical Remission in Severe AsthmaRecruiting
NCT07735494NAUpdated Aug 17, 2026
Sponsor: University of Leeds
Severe Asthma
United Kingdom
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaRecruiting
NCT06023589Phase 3Updated Aug 17, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, Brazil, Canada, China +17 more
Beclometasone Dipropionate and Formoterol Inhalation Aerosol for AsthmaRecruiting
NCT07768891Phase 3Updated Aug 17, 2026
Sponsor: Lunan Better Pharmaceutical Co., LTD.
Asthma (Diagnosis)
China
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 AsthmaRecruiting
NCT07456033Phase 3Updated Aug 17, 2026
Sponsor: GlaxoSmithKline
Asthma
United States, United Kingdom
Asthma Exacerbations & Respiratory Management International SurveyCompleted
NCT06652542N/AUpdated Aug 17, 2026
Sponsor: Assiut University
Acute Asthma Exacerbations
Egypt, Spain
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaRecruiting
NCT07323654Phase 2Updated Aug 17, 2026
Sponsor: Kymera Therapeutics, Inc.
Eosinophilic Asthma
United States, Argentina, Germany, Poland, Romania +5 more
Severe Asthma Research ProgramCompleted
NCT01606826N/AUpdated Aug 14, 2026
Sponsor: Milton S. Hershey Medical Center
Asthma
United States
Characterization of Adult Subjects for Asthmatic Research StudiesSuspended
NCT01508078N/AUpdated Aug 14, 2026
Sponsor: University of California, San Francisco
Asthma
United States

Previous page Next page